Text Size

Tübingen High Altitude Ophthalmology Study (THAO)

This study has been completed.
Sponsor:
Information provided by:
University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT01245114
First received: November 19, 2010
Last updated: December 2, 2010
Last verified: July 2010
History of Changes
  Purpose

Tuebingen High Altitude Ophthalmology Study to investigate the effects of high altitude on retinal structure and function as well as anterior chamber in regard to acute mountain sickness.


Condition
Altitude
Hypoxia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Tübingen High Altitude Ophthalmology Study (THAO)

Further study details as provided by University Hospital Tuebingen:

Study Completion Date: December 2010
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

healthy volunteers

Criteria

Inclusion Criteria:

  • healthy subjects, non-smokers, physical fitness,

Exclusion Criteria:

  • ocular pathologies, ascent above 2000m 2 weeks prior to study and 2 weeks before post-examination
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01245114

Locations
Germany
Eye Hospital, University of Tübingen
Tübingen, BW, Germany, 72076
Sponsors and Collaborators
University Hospital Tuebingen
Investigators
Study Director: Florian Gekeler, MD Eye Hospital, University of Tübingen, Germany
Principal Investigator: Gabriel Willmann, MD Eye Hospital, University of Tübingen, Germany
  More Information

No publications provided

Responsible Party: Prof. Florian Gekeler, Eye Hospital, University Hospital Tübingen, Germany
ClinicalTrials.gov Identifier: NCT01245114     History of Changes
Other Study ID Numbers: THAO
Study First Received: November 19, 2010
Last Updated: December 2, 2010
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Anoxia
Signs and Symptoms, Respiratory
Signs and Symptoms

ClinicalTrials.gov processed this record on May 16, 2013